Solventum Corporation · Healthcare
$76.56
-11.1%
Jun 17, 2026
D
WeakGraded against SOLV's own history at this drawdown — not the market's.
What it means: SOLV's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temp
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: SOLV is 11.1% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
Right now SOLV — Solventum — is in a moderate correction, down 11.1% from its record high. Last price: $76.56. Corrections in this band are common during macro repricings (rate scares, sector rotations, earnings shocks). The question is whether the cause is durable or transient.
SOLV reaches this drawdown band repeatedly in its history (178 observations), which is a meaningful sample for the segmentation engine to compute a stable median forward return. The engine uses a rolling 90-day window and gives more weight to recent years — this lets the signal adapt to regime changes (e.g., post-COVID volatility) without losing the long-run base rate.
For US large-caps, drawdowns of 20-30% are typically driven by macro repricing (rates, earnings, sector rotation). Single-name 50%+ drawdowns are usually structural — the signal alone won't tell you which, but the segments table will show whether prior episodes recovered. This is the band where most successful "buy the dip" strategies have historically operated. The median forward return here for SOLV is in the full app, alongside the segment-level win rate.
Five tickers closest to SOLV's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for SOLV. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of SOLV's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for SOLV.
Dipsern is research and a second opinion — not a broker. You'd buy SOLV at your own broker.
Analyze SOLV FreeNo credit card required · 5 free analyses per month
Signal computed Jun 17, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.